课题基金 / 基金详情

A prospective study evaluating complement activation among pregnant patients with obstetrical antiphospholipid syndrome

A prospective study evaluating complement activation among pregnant patients with obstetrical antiphospholipid syndrome
一项评估产科抗磷脂综合征妊娠患者补体激活的前瞻性研究
批准号:
405079
负责人:
Skeith Leslie
金额:
$7.65万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-05-01 至 2022-05-01

项目摘要

项目成果

Skeith Leslie的其他基金

相似基金

相关文献

中文摘要
翻译
抗磷脂综合征(APS)是一种自身免疫性疾病,可导致血栓(血栓形成)或妊娠并发症,如流产、先兆子痫或因胎盘功能不全引起的宫内生长受限。APS的原因
英文摘要
Antiphospholipid syndrome (APS) is an autoimmune disease that can lead to blood clots (thrombosis) or complications in pregnancy such as pregnancy loss, pre-eclampsia or intrauterine growth restriction because of placental insufficiency. The cause of APS
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial
  • 批准号:
    498295
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2023
  • 负责人:
    Skeith Leslie
  • 依托单位:
A prospective cohort study evaluating peripartum anticoagulation management among pregnant women with VTE and its impact on patient outcomes
  • 批准号:
    434526
  • 项目类别:
    Operating Grants
  • 资助金额:
    $54.06万
  • 财政年份:
    2020
  • 负责人:
    Skeith Leslie
  • 依托单位:
海外基金